Jönsson E G, Nimgaonkar V L, Zhang X R, Shaw S H, Burgert E, Crocq M A, Chakravarti A, Sedvall G C
Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institute, Stockholm, Sweden.
Am J Med Genet. 1999 Aug 20;88(4):352-7.
There is considerable controversy regarding a putative association between schizophrenia and a biallelic BalI polymorphism in the first exon of the dopamine D3 receptor gene (DRD3), although meta-analyses of published data suggest an association. If such an association exists, it may be detectable at markers physically close to DRD3. Accordingly, we conducted a case-control association study using D3S1310, a short tandem repeat polymorphism located approximately 700 kb telomeric to DRD3 on chromosome 3q13.3. The subjects were Swedish patients with schizophrenia (DSM III-R criteria, n = 110) and screened adult controls (n = 83). A trend for a negative association with the 141 bp allele was detected (chi2 = 7.6, d.f. = 1, P = 0.006; odds ratio 0.46, 95% confidence intervals 0.26, 0.81). However, following corrections for multiple comparisons using subgroups (n = 15) the difference was not significant. Also, due to the risk for population stratification in case-control association studies the results must be treated as tentative. If replicated the results may lend further support for the proposition of an association between schizophrenia and DRD3 or a gene in close proximity to DRD3 on chromosome 3q.
尽管对已发表数据的荟萃分析表明多巴胺D3受体基因(DRD3)第一外显子中的双等位基因BalI多态性与精神分裂症之间存在假定关联,但关于这一关联仍存在相当大的争议。如果存在这样的关联,那么在与DRD3物理距离较近的标记处可能检测得到。因此,我们使用D3S1310进行了一项病例对照关联研究,D3S1310是位于3号染色体3q13.3上DRD3端粒约700 kb处的一个短串联重复多态性。研究对象为瑞典的精神分裂症患者(符合DSM III-R标准,n = 110)和经过筛查的成年对照者(n = 83)。检测到与141 bp等位基因呈负相关的趋势(卡方 = 7.6,自由度 = 1,P = 0.006;优势比0.46,95%置信区间0.26, 0.81)。然而,在使用亚组(n = 15)对多重比较进行校正后,差异并不显著。此外,由于病例对照关联研究中存在群体分层的风险,该结果必须视为初步结果。如果能够重复验证,这些结果可能会进一步支持精神分裂症与DRD3或3号染色体3q上与DRD3紧密相邻的一个基因之间存在关联这一观点。